Orexin Receptors

The orexins (hypocretins) are a newly discovered family of neuropeptides which play a role in regulating feeding and wakefulness. The family currently consists of two members; orexin A and orexin B (33- and 28-residues respectively), which are produced from a common precursor prepro-orexin (130 amino acids). Cell bodies of orexin-containing neurons are largely confined to the lateral hypothalamus, an area classically linked to feeding stimulation. Intracerebroventricular injections of orexin A and orexin B stimulate feeding in a dose-related manner, with orexin A being significantly more effective than orexin B. Orexins are also strongly linked to the regulation of sleep-activity cycles, which may restrict the use of orexin ligands in the treatment of obesity. The orexins activate two G-protein-coupled receptors (OX1 and OX2) also found predominantly in the hypothalamus. Orexin A is the selective endogenous agonist for OX1 and blocking this receptor modulates food and water intake.

Receptor Data

Orexin Receptor Target Files

Related Targets

    Literature for Orexin Receptors


    GPCR Product Listing

    A collection of over 450 products for G protein-coupled receptors, the listing includes research tools for the study of:

    • Rhodopsin-like Receptors
    • Secretin-like Receptors
    • Glutamate Receptors
    • Frizzled Receptors
    • GPCR Signaling
    Peptide Hormone Receptors

    Peptide Hormone Receptors Product Listing

    A collection of over 200 products for peptide hormone receptors, the listing includes research tools for the study of:

    • Anterior Pituitary Regulation
    • Blood Pressure Regulation
    • Feeding and Appetite Regulation
    • Glucose Regulation
    • Peptide Hormone Processing
    Peptides Involved in Appetite Modulation

    Peptides Involved in Appetite Modulation Scientific Review

    Written by Sonia Tucci, Lynsay Kobelis and Tim Kirkham, this review provides a synopsis of the increasing number of peptides that have been implicated in appetite regulation and energy homeostasis; putative roles of the major peptides are outlined and compounds available from Tocris are listed.

    Orexin Receptor Data

    Receptor Subtype OX1 Receptors OX2 Receptors
    G protein Gq/11 Gq/11
    Transduction Mechanism ↑ PLC → ↑ Ca2+ influx ↑ PLC → ↑ Ca2+ influx
    Primary Locations Ventromedial hypothalamus, locus coeruleus, median raphe, hippocampus, tenia tecta Cerebral cortex (layers IV-VI), medial hypothalamus, paraventricular hypothalamus, nucleus accumbens, subthalamic and paraventricular thalamus, anterior pretectal nucleus
    Likely Physiological Roles Sleep-wakefulness, energy homeostasis Sleep-wakefulness

    Key Compounds Ki Values (nM)
    Orexin A (human, rat, mouse) (1455) 20 38
    Orexin B (human) (1456) 420 36
    SB 334867 (1960) 7.2* < 5*
    SB 408124 (1963) 21.7 1405
    [Ala11,D-Leu15-Orexin B (2142) 52 0.13

    * pKb value, † Kb value, ‡ EC50 value


    Smart et al (1999) Cahracterization of recombinant human orexin receptor pharmacology in a Chinese hamster ovary cell line using FLIPR. Br.J.Pharmacol. 128 1. Sutcliffe and de Lecea (2000) The hypocretins: excitatory neuromodulatory peptides for multiple homeostatic systems, including sleep and feeding. J.Neurosci. Res. 62 161. Smart (1999) Orexins: a new family of neuropeptides. Br.J.Anaesth. 83 695. Smart et al (2001) SB-334867-A: the first selective orexin-1 receptor antagonist. Br.J.Pharmacol. 132 1179. Asahi et al (2003) Development of an Orexin-2 receptor selective agonist [Ala11,D-Leu15orexin -B. Bioorg.Med.Chem.Letts. 13 111. Langmead et al (2004) Characterisation of the binding of [3H]-SB-674042, a novel nonpeptide antagonist, to the human orexin-1 receptor. Br.J.Pharmacol. 141 340.